Evidence map›Paper›PMID 29891820›Full record

ArticleMolecules (Basel, Switzerland)2018

(2

Hee Jin Jung, A Kyoung Lee, Yeo Jin Park, Sanggwon Lee, Dongwan Kang, Young Suk Jung, Hae Young Chung, Hyung Ryong Moon

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Design and Synthesis of (Antioxidants (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Article
  5. Novel Anti-Melanogenic Compounds, (Molecules (Basel, Switzerland) · 2021
    Article
  6. Article
  7. ThymocidNutrients · 2020
    Article
  8. Computational and structural biotechnology journal · 2019
    Article
  9. A Potent Tyrosinase Inhibitor, (Molecules (Basel, Switzerland) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hee Jin JungMolecular Inflammation Research Center for Aging Intervention (MRCA), Pusan National University, Busan 46241, Korea. hjjung2046@pusan.ac.kr.
A Kyoung LeeMolecular Inflammation Research Center for Aging Intervention (MRCA), Pusan National University, Busan 46241, Korea. lak000@naver.com.
Yeo Jin ParkMolecular Inflammation Research Center for Aging Intervention (MRCA), Pusan National University, Busan 46241, Korea. pyjin5526@gmail.com.
Sanggwon LeeMolecular Inflammation Research Center for Aging Intervention (MRCA), Pusan National University, Busan 46241, Korea. lsk3232@pusan.ac.kr.
Dongwan KangMolecular Inflammation Research Center for Aging Intervention (MRCA), Pusan National University, Busan 46241, Korea. 3607@pusan.ac.kr.
Young Suk JungMolecular Inflammation Research Center for Aging Intervention (MRCA), Pusan National University, Busan 46241, Korea. youngjung@pusan.ac.kr.
Hae Young ChungMolecular Inflammation Research Center for Aging Intervention (MRCA), Pusan National University, Busan 46241, Korea. hyjung@pusan.ac.kr.
Hyung Ryong MoonMolecular Inflammation Research Center for Aging Intervention (MRCA), Pusan National University, Busan 46241, Korea. mhr108@pusan.ac.kr.ORCID 0000-0003-1119-7112
Pusan National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultraviolet (UV) radiation exposure is the primary cause of extrinsic skin aging, which results in skin hyperpigmentation and wrinkling. In this study, we investigated the whitening effect of (2

Indexed as

AnimalsCyclopentanesDown-RegulationFibroblastsMelaninsMelanoma, ExperimentalMicePhosphorylationSkin AgingUltraviolet RaysCyclopentanescyclopentanoneMelanins(2E,5E)-2,5-Bis(3-hydroxy-4-methoxybenzylidene)cyclopentanone (BHCP)anti-melanogenesisanti-wrinkletyrosinase inhibitor

Identifiers

PMID29891820
PMCPMC6099591
OpenAlexW2805975731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.